Fenestrated and branched endovascular aortic repair (F-BEVAR)
ProcedureFenestrated and branched endovascular aortic repair (F-BEVAR)
NCT Number: NCT05247944
The aim of the present study was to investigate outcomes of a propensity matched series of patients treated with F-BEVAR and open surgery repair for complex abdominal aortic aneurysm in two aortic high-volume centres.
Looking for future studies?
Notify MeAll sexes
Observational
This retrospective study analyzes the long-term outcomes of a propensity-matched cohort of patients with complex abdominal aortic aneurysm prospectively collected between January 2010 and June 2016 from the Aortic Center of Lille (Lille, France) and the Unit of Vascular Surgery of Policlinic Gemelli (Rome, Italy).
Patients were observed with regular postoperative appointments. The long-term imaging follow-up consisted in a yearly computed tomography angiography in the F-BEVAR group; and yearly abdominal ultrasound examination and 5-year computed tomography angiography were performed in the open surgery repair group. In case of abnormal renal function (eGFR<60 mL/min/1.73 m2), the patient underwent computed tomography without contrast associated to a contrast-enhanced ultrasound examination in both groups. Laboratory data with evaluation of renal function by estimated glomerular filtration rate (eGFR), were completed at three, six, and 12 months, and yearly thereafter. Survival assessment was completed after general partitioner's, patients' or patient siblings' contact by phone.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fenestrated and branched endovascular aortic repair (F-BEVAR)
Open surgery for complex abdominal aortic aneurysm
Time frame: Through study completion, an average of 5 year
All cause death
Time frame: Through study completion, an average of 5 year
Any death related to the initial procedure.
Time frame: Through study completion, an average of 5 year
Chronic renal decline was defined in patients with normal (stage 1-2) preoperative renal function as a reduction in the eGFR to <60 mL/min/1.73 m2 during follow-up. In patients with abnormal function (stages 3 and 4) preoperatively, it was defined as an eGFR reduction of >20% or de novo dependence on permanent renal replacement therapy.
Time frame: Through study completion, an average of 5 year
All secondary interventions related to the initial procedure or to the endograft and its target vessels during follow-up
Time frame: Through study completion, an average of 5 year
Complete obstruction of the artery with no evidence of flow identified on any follow-up CT scan or duplex ultrasound.
Time frame: Through study completion, an average of 5 year
Death from complications of the initial operation or a secondary intervention, aortic aneurysm rupture, aortic conversion to open surgical repair, persistent type I or III endoleak, sac expansion >5 mm, device migration >10mm, infection or thrombosis in the F-BEVAR group and death, graft infection or thrombosis or para-anastomotic aneurysm in the open group.
Time frame: Through study completion, an average of 5 year
Diameter increase >5 mm within 5 cm above the ostium of the more proximal target vessel for the endovascular group and 5 cm above the proximal anastomosis for the open group
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
Propensity Matched Comparison of Fenestrated Endovascular Aneurysm Repair and Open Surgical Repair for Complex Abdominal Aortic Aneurysms.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03534440
Aneurysm, Aneurysm Aortic
Warsaw, Mazovian, Poland
View Trial DetailsNCT07282717
Aneurysm, Aneurysm Aortic
San Donato Milanese, Italy
View Trial DetailsNCT07441564
Aneurysm, Aneurysm Aortic
Dijon, France
View Trial DetailsNCT07453251
Aneurysm, Aneurysm Aortic
San Donato Milanese, MI, Italy
View Trial Details